A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

Scientists say a new blood test may detect the risk of dementia decades before memory problems begin, offering a potential ...

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that an abstract from its SUNRISE-PD study evaluating its lead candidate bezisterim (NE3107) for Parkinson’s disease has been accepted for presentation ...

BioVie Inc. (NASDAQ: BIVI) ('BioVie” or the 'Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Alzheimer’s disease is widely known for its most visible symptoms, such as memory loss, confusion, and difficulty thinking clearly. These changes often appear slowly and become worse over time.

Researchers led by a scientist at UC San Diego examined blood samples collected in the 1990s to detect a key biomarker’s presence.

Past research has linked Alzheimer's disease to problems with the chemical channels that produce energy in brain cells. One ...

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

Dementia is one of the biggest health challenges facing aging populations around the world. Millions of people develop memory loss and thinking problems as they grow older, and Alzheimer’s disease is ...